The global Volatile Anaesthetic Agents market was valued at US$ 1055 million in 2025 and is anticipated to reach US$ 1375 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Volatile Anaesthetic Agents Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Volatile Anaesthetic Agents competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Volatile Anaesthetic Agents are volatile liquids or gases that are breathed in through the lungs to produce and maintain general anaesthesia, causing a controlled, reversible state of unconsciousness along with reduced pain perception, amnesia, and suppression of movement and reflexes during surgery or procedures. They are delivered via an anaesthesia machine and vaporizer (for volatile liquids) or as a medical gas, mixed with oxygen or air and titrated in real time by adjusting the inspired concentration; their clinical effect depends largely on how they move from the lungs into the bloodstream and then the brain, which is influenced by factors like blood–gas solubility (speed of onset and recovery), ventilation, and cardiac output. Common examples include sevoflurane, isoflurane, desflurane, and nitrous oxide, chosen based on desired speed, haemodynamic stability, airway tolerance, and patient factors; while generally safe under monitoring, they can cause side effects such as low blood pressure, respiratory depression, postoperative nausea and vomiting, and—rarely—malignant hyperthermia in susceptible individuals. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.

Upstream for Volatile Anaesthetic Agents begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO₂ absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.

The North American market for Volatile Anaesthetic Agents is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Volatile Anaesthetic Agents is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Volatile Anaesthetic Agents include Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Volatile Anaesthetic Agents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Volatile Anaesthetic Agents. The Volatile Anaesthetic Agents market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Volatile Anaesthetic Agents market comprehensively. Regional market sizes by Type, by Application, by MAC, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Volatile Anaesthetic Agents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Volatile Anaesthetic Agents Market Report

Report Metric	Details
Report Name	Volatile Anaesthetic Agents Market
Accounted market size in 2025	US$ 1055 million
Forecasted market size in 2032	US$ 1375 million
CAGR	3.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Heptafluoroane Desflurane Isoflurane Others
Segment by MAC	Below 3% Above 3%
by Application	Human Use Animal Use
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by MAC, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Volatile Anaesthetic Agents manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Volatile Anaesthetic Agents sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Volatile Anaesthetic Agents Market growing?

Ans: The Volatile Anaesthetic Agents Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Volatile Anaesthetic Agents Market size in 2032?

Ans: The Volatile Anaesthetic Agents Market size in 2032 will be US$ 1375 million.

Who are the main players in the Volatile Anaesthetic Agents Market report?

Ans: The main players in the Volatile Anaesthetic Agents Market are Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer

What are the Application segmentation covered in the Volatile Anaesthetic Agents Market report?

Ans: The Applications covered in the Volatile Anaesthetic Agents Market report are Human Use, Animal Use

What are the Type segmentation covered in the Volatile Anaesthetic Agents Market report?

Ans: The Types covered in the Volatile Anaesthetic Agents Market report are Heptafluoroane, Desflurane, Isoflurane, Others

1 Volatile Anaesthetic Agents Market Overview

1.1 Product Definition

1.2 Volatile Anaesthetic Agents by Type

1.2.1 Global Volatile Anaesthetic Agents Market Value by Type: 2025 vs 2032

1.2.2 Heptafluoroane

1.2.3 Desflurane

1.2.4 Isoflurane

1.2.5 Others

1.3 Volatile Anaesthetic Agents by MAC

1.3.1 Global Volatile Anaesthetic Agents Market Value by MAC: 2025 vs 2032

1.3.2 Below 3%

1.3.3 Above 3%

1.4 Volatile Anaesthetic Agents by Application

1.4.1 Global Volatile Anaesthetic Agents Market Value by Application: 2025 vs 2032

1.4.2 Human Use

1.4.3 Animal Use

1.5 Global Volatile Anaesthetic Agents Market Size Estimates and Forecasts

1.5.1 Global Volatile Anaesthetic Agents Revenue 2021–2032

1.5.2 Global Volatile Anaesthetic Agents Sales 2021–2032

1.5.3 Global Volatile Anaesthetic Agents Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2 Volatile Anaesthetic Agents Market Competition by Manufacturers

2.1 Global Volatile Anaesthetic Agents Sales Market Share by Manufacturers (2021–2026)

2.2 Global Volatile Anaesthetic Agents Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Volatile Anaesthetic Agents Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Volatile Anaesthetic Agents, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Volatile Anaesthetic Agents, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Volatile Anaesthetic Agents, Product Types and Applications

2.7 Global Key Manufacturers of Volatile Anaesthetic Agents, Date of Entry into the Industry

2.8 Global Volatile Anaesthetic Agents Market Competitive Situation and Trends

2.8.1 Global Volatile Anaesthetic Agents Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Volatile Anaesthetic Agents Players Market Share by Revenue

2.8.3 Global Volatile Anaesthetic Agents Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Volatile Anaesthetic Agents Market Scenario by Region

3.1 Global Volatile Anaesthetic Agents Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Volatile Anaesthetic Agents Sales by Region: 2021–2032

3.2.1 Global Volatile Anaesthetic Agents Sales by Region: 2021–2026

3.2.2 Global Volatile Anaesthetic Agents Sales by Region: 2027–2032

3.3 Global Volatile Anaesthetic Agents Revenue by Region: 2021–2032

3.3.1 Global Volatile Anaesthetic Agents Revenue by Region: 2021–2026

3.3.2 Global Volatile Anaesthetic Agents Revenue by Region: 2027–2032

3.4 North America Volatile Anaesthetic Agents Market Facts & Figures by Country

3.4.1 North America Volatile Anaesthetic Agents Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Volatile Anaesthetic Agents Sales by Country (2021–2032)

3.4.3 North America Volatile Anaesthetic Agents Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Volatile Anaesthetic Agents Market Facts & Figures by Country

3.5.1 Europe Volatile Anaesthetic Agents Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Volatile Anaesthetic Agents Sales by Country (2021–2032)

3.5.3 Europe Volatile Anaesthetic Agents Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Volatile Anaesthetic Agents Market Facts & Figures by Region

3.6.1 Asia Pacific Volatile Anaesthetic Agents Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Volatile Anaesthetic Agents Sales by Region (2021–2032)

3.6.3 Asia Pacific Volatile Anaesthetic Agents Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Volatile Anaesthetic Agents Market Facts & Figures by Country

3.7.1 Latin America Volatile Anaesthetic Agents Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Volatile Anaesthetic Agents Sales by Country (2021–2032)

3.7.3 Latin America Volatile Anaesthetic Agents Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Volatile Anaesthetic Agents Market Facts & Figures by Country

3.8.1 Middle East and Africa Volatile Anaesthetic Agents Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Volatile Anaesthetic Agents Sales by Country (2021–2032)

3.8.3 Middle East and Africa Volatile Anaesthetic Agents Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Volatile Anaesthetic Agents Sales by Type (2021–2032)

4.1.1 Global Volatile Anaesthetic Agents Sales by Type (2021–2026)

4.1.2 Global Volatile Anaesthetic Agents Sales by Type (2027–2032)

4.1.3 Global Volatile Anaesthetic Agents Sales Market Share by Type (2021–2032)

4.2 Global Volatile Anaesthetic Agents Revenue by Type (2021–2032)

4.2.1 Global Volatile Anaesthetic Agents Revenue by Type (2021–2026)

4.2.2 Global Volatile Anaesthetic Agents Revenue by Type (2027–2032)

4.2.3 Global Volatile Anaesthetic Agents Revenue Market Share by Type (2021–2032)

4.3 Global Volatile Anaesthetic Agents Price by Type (2021–2032)

5 Segment by Application

5.1 Global Volatile Anaesthetic Agents Sales by Application (2021–2032)

5.1.1 Global Volatile Anaesthetic Agents Sales by Application (2021–2026)

5.1.2 Global Volatile Anaesthetic Agents Sales by Application (2027–2032)

5.1.3 Global Volatile Anaesthetic Agents Sales Market Share by Application (2021–2032)

5.2 Global Volatile Anaesthetic Agents Revenue by Application (2021–2032)

5.2.1 Global Volatile Anaesthetic Agents Revenue by Application (2021–2026)

5.2.2 Global Volatile Anaesthetic Agents Revenue by Application (2027–2032)

5.2.3 Global Volatile Anaesthetic Agents Revenue Market Share by Application (2021–2032)

5.3 Global Volatile Anaesthetic Agents Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Company Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Baxter Volatile Anaesthetic Agents Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 AbbVie

6.2.1 AbbVie Company Information

6.2.2 AbbVie Description and Business Overview

6.2.3 AbbVie Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 AbbVie Volatile Anaesthetic Agents Product Portfolio

6.2.5 AbbVie Recent Developments/Updates

6.3 Piramal Critical Care

6.3.1 Piramal Critical Care Company Information

6.3.2 Piramal Critical Care Description and Business Overview

6.3.3 Piramal Critical Care Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Piramal Critical Care Volatile Anaesthetic Agents Product Portfolio

6.3.5 Piramal Critical Care Recent Developments/Updates

6.4 Fresenius Kabi

6.4.1 Fresenius Kabi Company Information

6.4.2 Fresenius Kabi Description and Business Overview

6.4.3 Fresenius Kabi Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Fresenius Kabi Volatile Anaesthetic Agents Product Portfolio

6.4.5 Fresenius Kabi Recent Developments/Updates

6.5 Halocarbon

6.5.1 Halocarbon Company Information

6.5.2 Halocarbon Description and Business Overview

6.5.3 Halocarbon Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Halocarbon Volatile Anaesthetic Agents Product Portfolio

6.5.5 Halocarbon Recent Developments/Updates

6.6 Aspen

6.6.1 Aspen Company Information

6.6.2 Aspen Description and Business Overview

6.6.3 Aspen Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Aspen Volatile Anaesthetic Agents Product Portfolio

6.6.5 Aspen Recent Developments/Updates

6.7 Pfizer

6.7.1 Pfizer Company Information

6.7.2 Pfizer Description and Business Overview

6.7.3 Pfizer Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Pfizer Volatile Anaesthetic Agents Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Maruishi Pharmaceutical

6.8.1 Maruishi Pharmaceutical Company Information

6.8.2 Maruishi Pharmaceutical Description and Business Overview

6.8.3 Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Maruishi Pharmaceutical Volatile Anaesthetic Agents Product Portfolio

6.8.5 Maruishi Pharmaceutical Recent Developments/Updates

6.9 Jiangsu Hengrui Medicine

6.9.1 Jiangsu Hengrui Medicine Company Information

6.9.2 Jiangsu Hengrui Medicine Description and Business Overview

6.9.3 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product Portfolio

6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates

6.10 Lunan Pharmaceutical

6.10.1 Lunan Pharmaceutical Company Information

6.10.2 Lunan Pharmaceutical Description and Business Overview

6.10.3 Lunan Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Lunan Pharmaceutical Volatile Anaesthetic Agents Product Portfolio

6.10.5 Lunan Pharmaceutical Recent Developments/Updates

6.11 Hikma Pharmaceuticals

6.11.1 Hikma Pharmaceuticals Company Information

6.11.2 Hikma Pharmaceuticals Description and Business Overview

6.11.3 Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Hikma Pharmaceuticals Volatile Anaesthetic Agents Product Portfolio

6.11.5 Hikma Pharmaceuticals Recent Developments/Updates

6.12 HeBei YiPin Pharmaceutical

6.12.1 HeBei YiPin Pharmaceutical Company Information

6.12.2 HeBei YiPin Pharmaceutical Description and Business Overview

6.12.3 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product Portfolio

6.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates

6.13 Dechra Pharmaceuticals

6.13.1 Dechra Pharmaceuticals Company Information

6.13.2 Dechra Pharmaceuticals Description and Business Overview

6.13.3 Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Dechra Pharmaceuticals Volatile Anaesthetic Agents Product Portfolio

6.13.5 Dechra Pharmaceuticals Recent Developments/Updates

6.14 Life Sciences

6.14.1 Life Sciences Company Information

6.14.2 Life Sciences Description and Business Overview

6.14.3 Life Sciences Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Life Sciences Volatile Anaesthetic Agents Product Portfolio

6.14.5 Life Sciences Recent Developments/Updates

6.15 Zhejiang AngLiKang Pharmaceutical

6.15.1 Zhejiang AngLiKang Pharmaceutical Company Information

6.15.2 Zhejiang AngLiKang Pharmaceutical Description and Business Overview

6.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product Portfolio

6.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates

6.16 Linde Healthcare

6.16.1 Linde Healthcare Company Information

6.16.2 Linde Healthcare Description and Business Overview

6.16.3 Linde Healthcare Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Linde Healthcare Volatile Anaesthetic Agents Product Portfolio

6.16.5 Linde Healthcare Recent Developments/Updates

6.17 Air Liquide

6.17.1 Air Liquide Company Information

6.17.2 Air Liquide Description and Business Overview

6.17.3 Air Liquide Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Air Liquide Volatile Anaesthetic Agents Product Portfolio

6.17.5 Air Liquide Recent Developments/Updates

6.18 Messer

6.18.1 Messer Company Information

6.18.2 Messer Description and Business Overview

6.18.3 Messer Volatile Anaesthetic Agents Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Messer Volatile Anaesthetic Agents Product Portfolio

6.18.5 Messer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Volatile Anaesthetic Agents Industry Chain Analysis

7.2 Volatile Anaesthetic Agents Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Volatile Anaesthetic Agents Production Mode & Process Analysis

7.4 Volatile Anaesthetic Agents Sales and Marketing

7.4.1 Volatile Anaesthetic Agents Sales Channels

7.4.2 Volatile Anaesthetic Agents Distributors

7.5 Volatile Anaesthetic Agents Customer Analysis

8 Volatile Anaesthetic Agents Market Dynamics

8.1 Volatile Anaesthetic Agents Industry Trends

8.2 Volatile Anaesthetic Agents Market Drivers

8.3 Volatile Anaesthetic Agents Market Challenges

8.4 Volatile Anaesthetic Agents Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Baxter

AbbVie

Piramal Critical Care

Maruishi Pharmaceutical

Jiangsu Hengrui Medicine

Lunan Pharmaceutical

Hikma Pharmaceuticals

Hebei Yipin Pharmaceutical

Dechra Pharmaceuticals

Life Sciences

Zhejiang Anglikang Pharmaceutical

Linde Healthcare

Air Liquide

Messer

List of Tables

Table 1. Global Volatile Anaesthetic Agents Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Volatile Anaesthetic Agents Market Value by MAC (US$ Million), 2025 vs 2032

Table 3. Global Volatile Anaesthetic Agents Market Value by Application (US$ Million), 2025 vs 2032

Table 4. Global Volatile Anaesthetic Agents Market Competitive Situation by Manufacturers in 2025

Table 5. Global Volatile Anaesthetic Agents Sales (Tons) of Key Manufacturers (2021–2026)

Table 6. Global Volatile Anaesthetic Agents Sales Market Share by Manufacturers (2021–2026)

Table 7. Global Volatile Anaesthetic Agents Revenue (US$ Million) by Manufacturers (2021–2026)

Table 8. Global Volatile Anaesthetic Agents Revenue Share by Manufacturers (2021–2026)

Table 9. Global Market Volatile Anaesthetic Agents Average Price (US$/kg) of Key Manufacturers (2021–2026)

Table 10. Global Key Players of Volatile Anaesthetic Agents, Industry Ranking, 2023 vs 2024 vs 2025

Table 11. Global Key Manufacturers of Volatile Anaesthetic Agents, Manufacturing Sites and Headquarters

Table 12. Global Key Manufacturers of Volatile Anaesthetic Agents, Product Types and Applications

Table 13. Global Key Manufacturers of Volatile Anaesthetic Agents, Date of Entry into the Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Volatile Anaesthetic Agents Companies by Tier (Tier 1, Tier 2, Tier 3), based on Volatile Anaesthetic Agents Revenue, 2025

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Volatile Anaesthetic Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Volatile Anaesthetic Agents Sales by Region (Tons), 2021–2026

Table 19. Global Volatile Anaesthetic Agents Sales Market Share by Region (2021–2026)

Table 20. Global Volatile Anaesthetic Agents Sales by Region (Tons), 2027–2032

Table 21. Global Volatile Anaesthetic Agents Sales Market Share by Region (2027–2032)

Table 22. Global Volatile Anaesthetic Agents Revenue by Region (US$ Million), 2021–2026

Table 23. Global Volatile Anaesthetic Agents Revenue Market Share by Region (2021–2026)

Table 24. Global Volatile Anaesthetic Agents Revenue by Region (US$ Million), 2027–2032

Table 25. Global Volatile Anaesthetic Agents Revenue Market Share by Region (2027–2032)

Table 26. North America Volatile Anaesthetic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 27. North America Volatile Anaesthetic Agents Sales by Country (Tons), 2021–2026

Table 28. North America Volatile Anaesthetic Agents Sales by Country (Tons), 2027–2032

Table 29. North America Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2021–2026

Table 30. North America Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2027–2032

Table 31. Europe Volatile Anaesthetic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 32. Europe Volatile Anaesthetic Agents Sales by Country (Tons), 2021–2026

Table 33. Europe Volatile Anaesthetic Agents Sales by Country (Tons), 2027–2032

Table 34. Europe Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2021–2026

Table 35. Europe Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2027–2032

Table 36. Asia Pacific Volatile Anaesthetic Agents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia Pacific Volatile Anaesthetic Agents Sales by Region (Tons), 2021–2026

Table 38. Asia Pacific Volatile Anaesthetic Agents Sales by Region (Tons), 2027–2032

Table 39. Asia Pacific Volatile Anaesthetic Agents Revenue by Region (US$ Million), 2021–2026

Table 40. Asia Pacific Volatile Anaesthetic Agents Revenue by Region (US$ Million), 2027–2032

Table 41. Latin America Volatile Anaesthetic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 42. Latin America Volatile Anaesthetic Agents Sales by Country (Tons), 2021–2026

Table 43. Latin America Volatile Anaesthetic Agents Sales by Country (Tons), 2027–2032

Table 44. Latin America Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2021–2026

Table 45. Latin America Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2027–2032

Table 46. Middle East and Africa Volatile Anaesthetic Agents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 47. Middle East and Africa Volatile Anaesthetic Agents Sales by Country (Tons), 2021–2026

Table 48. Middle East and Africa Volatile Anaesthetic Agents Sales by Country (Tons), 2027–2032

Table 49. Middle East and Africa Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2021–2026

Table 50. Middle East and Africa Volatile Anaesthetic Agents Revenue by Country (US$ Million), 2027–2032

Table 51. Global Volatile Anaesthetic Agents Sales (Tons) by Type (2021–2026)

Table 52. Global Volatile Anaesthetic Agents Sales (Tons) by Type (2027–2032)

Table 53. Global Volatile Anaesthetic Agents Sales Market Share by Type (2021–2026)

Table 54. Global Volatile Anaesthetic Agents Sales Market Share by Type (2027–2032)

Table 55. Global Volatile Anaesthetic Agents Revenue (US$ Million) by Type (2021–2026)

Table 56. Global Volatile Anaesthetic Agents Revenue (US$ Million) by Type (2027–2032)

Table 57. Global Volatile Anaesthetic Agents Revenue Market Share by Type (2021–2026)

Table 58. Global Volatile Anaesthetic Agents Revenue Market Share by Type (2027–2032)

Table 59. Global Volatile Anaesthetic Agents Price (US$/kg) by Type (2021–2026)

Table 60. Global Volatile Anaesthetic Agents Price (US$/kg) by Type (2027–2032)

Table 61. Global Volatile Anaesthetic Agents Sales (Tons) by Application (2021–2026)

Table 62. Global Volatile Anaesthetic Agents Sales (Tons) by Application (2027–2032)

Table 63. Global Volatile Anaesthetic Agents Sales Market Share by Application (2021–2026)

Table 64. Global Volatile Anaesthetic Agents Sales Market Share by Application (2027–2032)

Table 65. Global Volatile Anaesthetic Agents Revenue (US$ Million) by Application (2021–2026)

Table 66. Global Volatile Anaesthetic Agents Revenue (US$ Million) by Application (2027–2032)

Table 67. Global Volatile Anaesthetic Agents Revenue Market Share by Application (2021–2026)

Table 68. Global Volatile Anaesthetic Agents Revenue Market Share by Application (2027–2032)

Table 69. Global Volatile Anaesthetic Agents Price (US$/kg) by Application (2021–2026)

Table 70. Global Volatile Anaesthetic Agents Price (US$/kg) by Application (2027–2032)

Table 71. Baxter Company Information

Table 72. Baxter Description and Business Overview

Table 73. Baxter Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 74. Baxter Volatile Anaesthetic Agents Product

Table 75. Baxter Recent Developments/Updates

Table 76. AbbVie Company Information

Table 77. AbbVie Description and Business Overview

Table 78. AbbVie Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 79. AbbVie Volatile Anaesthetic Agents Product

Table 80. AbbVie Recent Developments/Updates

Table 81. Piramal Critical Care Company Information

Table 82. Piramal Critical Care Description and Business Overview

Table 83. Piramal Critical Care Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 84. Piramal Critical Care Volatile Anaesthetic Agents Product

Table 85. Piramal Critical Care Recent Developments/Updates

Table 86. Fresenius Kabi Company Information

Table 87. Fresenius Kabi Description and Business Overview

Table 88. Fresenius Kabi Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 89. Fresenius Kabi Volatile Anaesthetic Agents Product

Table 90. Fresenius Kabi Recent Developments/Updates

Table 91. Halocarbon Company Information

Table 92. Halocarbon Description and Business Overview

Table 93. Halocarbon Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 94. Halocarbon Volatile Anaesthetic Agents Product

Table 95. Halocarbon Recent Developments/Updates

Table 96. Aspen Company Information

Table 97. Aspen Description and Business Overview

Table 98. Aspen Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 99. Aspen Volatile Anaesthetic Agents Product

Table 100. Aspen Recent Developments/Updates

Table 101. Pfizer Company Information

Table 102. Pfizer Description and Business Overview

Table 103. Pfizer Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 104. Pfizer Volatile Anaesthetic Agents Product

Table 105. Pfizer Recent Developments/Updates

Table 106. Maruishi Pharmaceutical Company Information

Table 107. Maruishi Pharmaceutical Description and Business Overview

Table 108. Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 109. Maruishi Pharmaceutical Volatile Anaesthetic Agents Product

Table 110. Maruishi Pharmaceutical Recent Developments/Updates

Table 111. Jiangsu Hengrui Medicine Company Information

Table 112. Jiangsu Hengrui Medicine Description and Business Overview

Table 113. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 114. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product

Table 115. Jiangsu Hengrui Medicine Recent Developments/Updates

Table 116. Lunan Pharmaceutical Company Information

Table 117. Lunan Pharmaceutical Description and Business Overview

Table 118. Lunan Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 119. Lunan Pharmaceutical Volatile Anaesthetic Agents Product

Table 120. Lunan Pharmaceutical Recent Developments/Updates

Table 121. Hikma Pharmaceuticals Company Information

Table 122. Hikma Pharmaceuticals Description and Business Overview

Table 123. Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 124. Hikma Pharmaceuticals Volatile Anaesthetic Agents Product

Table 125. Hikma Pharmaceuticals Recent Developments/Updates

Table 126. HeBei YiPin Pharmaceutical Company Information

Table 127. HeBei YiPin Pharmaceutical Description and Business Overview

Table 128. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 129. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product

Table 130. HeBei YiPin Pharmaceutical Recent Developments/Updates

Table 131. Dechra Pharmaceuticals Company Information

Table 132. Dechra Pharmaceuticals Description and Business Overview

Table 133. Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 134. Dechra Pharmaceuticals Volatile Anaesthetic Agents Product

Table 135. Dechra Pharmaceuticals Recent Developments/Updates

Table 136. Life Sciences Company Information

Table 137. Life Sciences Description and Business Overview

Table 138. Life Sciences Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 139. Life Sciences Volatile Anaesthetic Agents Product

Table 140. Life Sciences Recent Developments/Updates

Table 141. Zhejiang AngLiKang Pharmaceutical Company Information

Table 142. Zhejiang AngLiKang Pharmaceutical Description and Business Overview

Table 143. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 144. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product

Table 145. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates

Table 146. Linde Healthcare Company Information

Table 147. Linde Healthcare Description and Business Overview

Table 148. Linde Healthcare Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 149. Linde Healthcare Volatile Anaesthetic Agents Product

Table 150. Linde Healthcare Recent Developments/Updates

Table 151. Air Liquide Company Information

Table 152. Air Liquide Description and Business Overview

Table 153. Air Liquide Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 154. Air Liquide Volatile Anaesthetic Agents Product

Table 155. Air Liquide Recent Developments/Updates

Table 156. Messer Company Information

Table 157. Messer Description and Business Overview

Table 158. Messer Volatile Anaesthetic Agents Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 159. Messer Volatile Anaesthetic Agents Product

Table 160. Messer Recent Developments/Updates

Table 161. Key Raw Materials Lists

Table 162. Raw Materials Key Suppliers Lists

Table 163. Volatile Anaesthetic Agents Distributors List

Table 164. Volatile Anaesthetic Agents Customers List

Table 165. Volatile Anaesthetic Agents Market Trends

Table 166. Volatile Anaesthetic Agents Market Drivers

Table 167. Volatile Anaesthetic Agents Market Challenges

Table 168. Volatile Anaesthetic Agents Market Restraints

Table 169. Research Programs/Design for This Report

Table 170. Key Data Information from Secondary Sources

Table 171. Key Data Information from Primary Sources

Table 172. Authors List of This Report

List of Figures

Figure 1. Product Picture of Volatile Anaesthetic Agents

Figure 2. Global Volatile Anaesthetic Agents Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Volatile Anaesthetic Agents Market Share by Type: 2025 & 2032

Figure 4. Heptafluoroane Product Picture

Figure 5. Desflurane Product Picture

Figure 6. Isoflurane Product Picture

Figure 7. Others Product Picture

Figure 8. Global Volatile Anaesthetic Agents Market Value by MAC (US$ Million), 2021–2032

Figure 9. Global Volatile Anaesthetic Agents Market Share by MAC: 2025 vs 2032

Figure 10. Below 3% Product Picture

Figure 11. Above 3% Product Picture

Figure 12. Global Volatile Anaesthetic Agents Market Value by Application (US$ Million), 2021–2032

Figure 13. Global Volatile Anaesthetic Agents Market Share by Application: 2025 & 2032

Figure 14. Human Use

Figure 15. Animal Use

Figure 16. Global Volatile Anaesthetic Agents Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Volatile Anaesthetic Agents Market Size (US$ Million), 2021–2032

Figure 18. Global Volatile Anaesthetic Agents Sales (Tons), 2021–2032

Figure 19. Global Volatile Anaesthetic Agents Average Price (US$/kg), 2021–2032

Figure 20. Volatile Anaesthetic Agents Report Years Considered

Figure 21. Volatile Anaesthetic Agents Sales Share by Manufacturers in 2025

Figure 22. Global Volatile Anaesthetic Agents Revenue Share by Manufacturers in 2025

Figure 23. Top 5 and Top 10 Global Volatile Anaesthetic Agents Players: Market Share by Revenue in Volatile Anaesthetic Agents in 2025

Figure 24. Volatile Anaesthetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 25. Global Volatile Anaesthetic Agents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 26. North America Volatile Anaesthetic Agents Sales Market Share by Country (2021–2032)

Figure 27. North America Volatile Anaesthetic Agents Revenue Market Share by Country (2021–2032)

Figure 28. United States Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Canada Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Europe Volatile Anaesthetic Agents Sales Market Share by Country (2021–2032)

Figure 31. Europe Volatile Anaesthetic Agents Revenue Market Share by Country (2021–2032)

Figure 32. Germany Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. France Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. U.K. Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Italy Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Russia Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Asia Pacific Volatile Anaesthetic Agents Sales Market Share by Region (2021–2032)

Figure 38. Asia Pacific Volatile Anaesthetic Agents Revenue Market Share by Region (2021–2032)

Figure 39. China Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Japan Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. South Korea Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. India Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Australia Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. China Taiwan Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Southeast Asia Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America Volatile Anaesthetic Agents Sales Market Share by Country (2021–2032)

Figure 47. Latin America Volatile Anaesthetic Agents Revenue Market Share by Country (2021–2032)

Figure 48. Mexico Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Colombia Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Middle East and Africa Volatile Anaesthetic Agents Sales Market Share by Country (2021–2032)

Figure 53. Middle East and Africa Volatile Anaesthetic Agents Revenue Market Share by Country (2021–2032)

Figure 54. Turkey Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Saudi Arabia Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. UAE Volatile Anaesthetic Agents Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Global Sales Market Share of Volatile Anaesthetic Agents by Type (2021–2032)

Figure 58. Global Revenue Market Share of Volatile Anaesthetic Agents by Type (2021–2032)

Figure 59. Global Volatile Anaesthetic Agents Price (US$/kg) by Type (2021–2032)

Figure 60. Global Sales Market Share of Volatile Anaesthetic Agents by Application (2021–2032)

Figure 61. Global Revenue Market Share of Volatile Anaesthetic Agents by Application (2021–2032)

Figure 62. Global Volatile Anaesthetic Agents Price (US$/kg) by Application (2021–2032)

Figure 63. Volatile Anaesthetic Agents Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions